in a prospective randomized trial 58 patients ( 46 men , 12 women ; mean age 41 [ 18-65 ] years ) with histologically proven chronic hepatitis b and demonstration of hbs antigen and hepatitis b virus dna in serum were randomly divided into two groups : 30 patients were treated with recombinant alpha 2b interferon .
C0524909
chronic hepatitis b
C0021735
recombinant alpha 2b interferon